Candidate stem/progenitor cells have been identified in mouse endometrium as label-retaining cells (LRCs). The role of endometrial stem/progenitor cells in initiating estrogen-stimulated endometrial growth in prepubertal and cycling mice was investigated following a single 17b-estradiol (E2) injection in bromodeoxyuridine (BrdU)-labeled and -chased (LRC), ovariectomised mice. Proliferating (BrdU þ /Ki-67 þ ) and mitotic (BrdU þ /PH3 þ ) epithelial LRCs were first detected in prepubertal mice 8 hours following E2 treatment, initiating the proliferative response. In contrast, all epithelial LRCs and 16% of epithelial cells in cycling mice proliferated within 2 hours. In cycling mice, 12% of stromal LRCs initiated a proliferative response 8 hours after E2. Proliferating epithelial LRCs and most stromal LRCs (85%) lacked estrogen receptor-a (ESR1). These findings suggest that endometrial epithelial LRCs function as stem/progenitor cells by receiving proliferative signals from neighboring ESR1 þ niche cells to initiate the growth of the epithelium during development, while mature epithelial cells may undergo self-replication in cycling endometrium.
Introduction
The endometrium is one of the few tissues in the adult human that undergoes cyclical shedding and rapid regeneration. Each month, the human endometrial mucosa grows 4 to 10 mm over a period of 4 to 7 days following menses for over 400 cycles during the reproductive years. [1] [2] [3] This regenerative capacity of human endometrium is similar to that of epidermis, intestine, and bone marrow. Recent evidence suggests that adult stem/progenitor cells present in human and mouse endometrium may be responsible for this remarkable regenerative capacity (reviewed in Gargett and Gargett et al 2007) . 3, 4 Cell cloning analysis identified a rare population of human endometrial epithelial and stromal cells which exhibited high proliferative potential in both normal cycling 5 and inactive endometrium. 6 The large colony-forming unit (CFU) epithelial cells exhibit self-renewal and differentiate into large gland-like structures in 3-D culture, while stromal CFU underwent substantial self-renewal and multilineage differentiation into 4 mesodermal lineages, 7 suggesting that human endometrium harbors epithelial progenitor and mesenchymal stem cell-like cell populations. 8 Likewise both epithelial and stromal label-retaining cells (LRCs) were identified in mouse endometrium and myometrium. [9] [10] [11] Epithelial and most stromal LRC did not express estrogen receptor-a (ER-a, ESR1), although 16% of stromal LRC were ESR1 þ . 9 Epithelial and stromal LRC underwent proliferation within 8 hours of 17-b estradiol administration, suggesting that they have capacity to act as stem/progenitor cells and may be responsible for endometrial regeneration. 9 Estradiol (E2) is obligatory for uterine function, with defined roles in endometrial cell viability, survival, and proliferation. 12 E2 elicits its effects via 2 ESR, ESR1 (ER-a) and ESR2 (ER-b), both members of the steroid hormone superfamily of transcription factors. Although both isoforms are expressed in the uterus, ESR1 predominates and mediates the majority of E2 signals in mouse endometrium, while ESR2 may modulate the proliferative effects of E2. 13, 14 Estrogen receptors are first detected in fetal Müllerian duct 15 ; however, this expression diminishes in the neonatal period and reappears in both endometrial epithelial and stromal cells of juvenile and adult mice. 16 Mice undergo cycles of growth and regression during each 4to 5-day estrus cycle rather than a menstrual cycle as seen in humans and other primates. The luminal epithelium proliferates in response to increasing plasma E2 levels and undergoes apoptosis when E2 levels decline. 17 These cellular dynamics observed during the estrus cycle can be reproduced in ovariectomized (OVX) mice by exogenous sex steroid hormone administration, providing a tractable system for examining cellular responses and their interplay with fluctuating hormone levels.
It is well accepted that stem/progenitor cells are found within the LRC population 18 since LRCs are clonogenic, 19 demonstrate plasticity, 20 and are involved in the regeneration of tissues. 21 However, not all LRCs are stem cells and it is important to demonstrate their functionality. In several tissues where LRCs have been identified, substantial damage or tissue ablation has been used to provoke quiescent LRC into cell cycle to initiate tissue replacement. 22 Label-retaining cells have also been shown to play a key role during natural growth and regression phases of the hair cycle without resorting to ablation strategies. 23, 24 The endometrium serves as another model for investigating the role of LRCs/stem/progenitor cells under dynamic physiological conditions without the need to inflict tissue damage by radio-or chemotherapy. The fate of LRCs can then be examined under steady state conditions in one of the few actively remodeling mammalian tissues. In this study, we hypothesized that endometrial LRC respond to E2 via ESR1 þ niche cells to enter the cell cycle and initiate the process of cellular replacement associated with endometrial growth and regeneration. Since there are differences in the sensitivity of endometrial epithelial cells to E2 in neonatal and adult uteri, 25 the overall objective of this study was to compare the effect of E2 on the proliferation kinetics of mouse endometrial epithelial and stromal LRC in prepubertal noncycling mice with those in mice undergoing regular estrus cycles. More specifically, we wished to examine whether epithelial and stromal LRC function as adult stem cells and proliferate in response to E2 to initiate endometrial regeneration in an OVX mouse model after a single physiological dose of E2. In this study, we showed a difference in the proliferative response to estrogen in endometrium from animals that have previously cycled versus those that had not. Our data suggest that although epithelial LRCs play a major role in initiating E2-stimulated epithelial cell growth during development in juvenile noncycling endometrium they appear to have a minor role in cycling endometrium. E2-induced stromal regeneration is considerably less than for epithelium involving a minority of the stromal LRC.
Materials and Methods

Animals and Housing Conditions
All mouse husbandry and experimental procedures were conducted in compliance with the protocols approved by the Monash Medical Centre Animal Ethics Committee A. Mice had access to food and water ad libitum and were placed on a soy-free diet at ovariectomy. Mice were housed under controlled environmental conditions at 20 C with a 12-hour dark/light cycle.
Estrogen Treatment of Bromodeoxyuridine Pulse-Labeled and -Chased Mice
All bromodeoxyuridine (BrdU)-labeled mice (C57BL/6J) were generated by administering 6 subcutaneous injections of BrdU in 0.9% saline from postnatal day (P) 3 to 5 (twice daily, at 9 AM and 4 PM for 3 consecutive days, 50 mg/g of body weight) using our established protocol 9 and randomly distributed into 2 groups. Mice were then allowed to grow without further labeling. One group was chased for 4 weeks and the other 8 weeks after which mice were OVX and the endometrium allowed to regress for 2 weeks, producing prepubertal never cycled LRC mice and cycling LRC mice, respectively ( Figure 1 ). These 2 groups of mice were randomly allocated into subgroups of 5 to 6 mice/group (104 mice used in total; chase period (CP)4 week, n ¼ 50; CP8 week, n ¼ 54) and given a single subcutaneous E2 injection (17b-estradiol, 100 ng/100 mL; Sigma-Aldrich, St. Louis, Missouri) or vehicle treatment (peanut oil, 100 mL) and chased a second time for 0, 2, 8, 16, 24, 48, 72, 96 , and 120 hours (n ¼ 5-6/timepoint/treatment; Figure 1A ). Mice were euthanized by cervical dislocation and the uterine horns harvested, the right horn fixed in 4% paraformaldehyde, the left in 10% formalin for 2 hours, and processed into paraffin blocks by standard techniques.
BrdU/Ki-67 Immunohistochemistry and Immunofluorescence Protocols
To visualize proliferating LRCs and their progeny, double immunohistochemistry (IHC) and immunofluorescence (IF) protocols for BrdU/Ki67 were undertaken as described previously, 9 with several modifications. Following antigen retrieval (0.1 mol/L citrate buffer, pH 6.0, microwave for 20 minutes) and mild acid hydrolysis (0.1 mol/L HCl for 45 minutes), sheep anti-BrdU antibody (8.4 mg/mL; Biodesign International, Saco, Maine) was applied for 1 hour, then labelled streptavidin biotin (LSAB) alkaline phosphatase-conjugated streptavidin (Dako Cytomation, Glostrup, Denmark) was incubated for 15 minutes followed by the Vector alkaline phosphatase substrate kit III (Vector Laboratories Inc, Burlingame, California) for 10 minutes to visualize the BrdU þ cells. Endogenous peroxidase was then quenched (0.3% H 2 O 2 , Orion Laboratories Pvt Ltd, Welshpool, WA, Australia) for 10 minutes and blocked with protein blocking agent (Immunon Thermo Shandon, Pittsburgh, Pennsylvania) for 10 minutes before incubation with rabbit polyclonal Ki-67 antibody 0.15 mg/mL (Novocastra Laboratories Ltd, Newcastle upon Tyne, England) diluted in 0.1% bovine serum albumin (BSA)/phosphate-buffered saline (PBS) for 1 hour, followed by biotinylated swine anti-rabbit immunoglobulin G ([IgG]; Dako Cytomation) for 30 minutes, then peroxidase-conjugated streptavidin (Dako Cytomation) for 15 minutes, and visualized with diaminobenzidine (DAB) chromogen (Sigma-Aldrich) for 5 minutes. Washing steps using PBS were conducted between each step, and all incubations were performed at room temperature unless otherwise specified. Isotype-matched negative controls, sheep IgG for BrdU (Sigma-Aldrich), and rabbit IgG for Ki-67 (Sigma-Aldrich), at the same concentration as the primary antibodies were included in every staining run. To examine for true colocalization of the proliferation marker Ki-67 and BrdU in LRC, a double IF protocol for BrdU/Ki67 was conducted using Alexa Fluor 488-and Alexa Fluor 568-conjugated secondary antibodies, respectively, (Molecular Probes Inc, Invitrogen Corp, Carlsbad, California), as described previously. 9
Detection of ESR1 in Proliferating LRC Using IF
To determine whether proliferating endometrial LRC coexpressed ESR1, a 3-mm serial section was double IF stained with the proliferation marker Ki-67 and BrdU (as above), and a second 3-mm serial section was double IF stained with ESR1 (mouse antihuman ESR clone 6F11, 3.5 mg/mL) and BrdU as described previously. 9 
BrdU/Phosphorylated Histone H3 (PH3) IHC and IF
To visualize mitotic LRC, double IHC and IF protocols for BrdU/PH3 were established. Paraffin sections (5 mm) were dewaxed, antigen retrieval and pretreatment were as described for the BrdU protocol. 9 Sections were then blocked with 10% donkey serum in 10% fetal calf serum/0.1% BSA/PBS for 30 minutes and then incubated with rabbit polyclonal phospho histone-3 antibody (PH3, 0.02 mg/mL; Cell Signaling Inc, Danvers, Massachusetts) in 0.1% BSA/PBS overnight at 4 C, followed by biotinylated swine anti-rabbit secondary antibody (Dako Cytomation) for 30 minutes. Slides were washed with Tris-buffered saline (TBS), incubated with Avidin:Biotinylated enzyme Complex (ABC) reagent (Vector Laboratories Inc) for 30 minutes and then with DAB chromogen (Sigma-Aldrich) for 5 minutes. The subsequent BrdU staining was carried out as described previously, 9 using Vector alkaline phosphatase substrate kit III as chromogen. To determine true colocalization of PH3 and BrdU in LRCs, the above protocol was adapted by substitution of secondary antibodies conjugated with fluorochromes Alexa Fluor 568-conjugated donkey anti-sheep IgG (Molecular Probes Inc) for BrdU and Alexa Fluor 488conjugated donkey anti-rabbit (Molecular Probes Inc) to detect PH3. Nuclei were counterstained with Hoechst 33258 (4 mg/ mL; Molecular Probes Inc) for 1 minute, washed with dH 2 O, and coversliped using fluorescent mounting medium (Dako Cytomation). Isotype-matched negative controls: sheep IgG for BrdU (Sigma-Aldrich), and rabbit IgG for PH3 (Sigma-Aldrich), at the same concentration as the primary antibodies were included in every staining run.
All IHC slides were examined under a Zeiss microscope (Axioskop, West Germany) and images captured using a digital video camera (Fujix, West Germany). Dual IF was detected using a Leica confocal microscope (Leica Microsystem, Heerbrugg, Switzerland). Images were captured with Leica confocal software version 2.5 and subsequently imported into Adobe Photoshop (version 8.0, Adobe Systems Inc, San Jose, California) where they were pseudocolored, image processed, and merged. Optical sectioning on the entire cell or nucleus through its z plane was done to provide 3-dimensional (3-D) images (x/y/z plane) to detect colocalization of nuclear markers.
Assessment of Labeling Indices
The number of BrdU þ , Ki-67 þ , BrdU þ Ki-67 þ , PH3 þ , and BrdU þ PH3 þ endometrial epithelial and stromal cells was counted separately in the entire area of single transverse and longitudinal sections from 1 uterine horn of 5 to 6 mice for each post-E2 time point for both 4-and 8-week chased groups in a blinded manner. The total number of epithelial and stromal nuclei was counted in each section of the double-labeled chromogen-stained sections by RWS Chan using the AIS software (version 3.0; AIS, Ontario, Canada); at least 200 to 1600 nuclei per uterine horn per mouse at each time point were counted. All epithelial and stromal LRC (BrdU þ , BrdU þ Ki-67 þ , and BrdU þ PH3 þ ) nuclei were counted in each section examined. The labeling index (LI) for BrdU þ , Ki-67 þ , BrdU þ Ki-67 þ , PH3 þ , and BrdU þ PH3 þ cells was calculated as a percentage of total epithelial or stromal cells for each section and reported as means + standard error of the mean (SEM) for each experimental group per time point. Only heavily immunostained BrdU, Ki-67, and PH3 nuclei were counted as labeled cells and those that had a speckled or faded appearance were considered to have undergone several cell divisions with subsequent dilution of the BrdU label and were not counted. Double IF slides were not assessed for LI in this study.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (version 4.00, GraphPad Software, San Diego, California). Data were tested for homogeneity of variance using Bartlett test and was found significant, and therefore nonparametic tests were used. The Kruskal-Wallis one-way analysis of variance followed by Dunn multiple comparison test was used for comparison between post-E2 time points within the treatment groups. Data are presented as mean + SEM. Results were considered statistically significant when P < .05.
Results
Role of LRC in Initiating Epithelial Proliferation in Prepubertal Endometrium
To establish the role of LRC in mediating E2-stimulated endometrial epithelial growth during the final stages of endometrial development, prepubertal LRC mice were OVX to regress the endometrium and treated with a single 17b-estradiol injection ( Figure 1A ). Within 14 days of OVX, the luminal epithelium is substantially diminished, glands have virtually disappeared, and there is dense packing of the remaining stromal cells ( Figure 1B and C). On administration of E2, the endometrium rapidly regenerated with growth of glands, expansion of luminal epithelial cells to pre-OVX numbers, and production of an enlarged edematous stroma ( Figure 1D ). The proliferation kinetics of endometrial epithelial cells and LRC were then examined during the first 120 hours of E2-induced endometrial regeneration in OVX mice. The percentage of epithelial LRC (BrdU þ ) was constant over this period with an average LI of 1.29% + 0.18% (n ¼ 9 time points, 4-6 animals/group; Figure 2A -F). The irregular shape of many BrdU þ nuclei (eg, Figure 2 ) is due to the incorporation of BrdU into the nonuniformly distributed chromatin. As BrdU þ cells undergo cell division and the BrdU label dilutes, the heterogeneity of staining becomes more obvious. 26, 27 Proliferating epithelial cells (Ki-67 þ ) were absent during the first 2 hours (Figure 2A and E) and were first detected in the luminal epithelium 8 hours after E2 ( Figure 2B , D, and E). Proliferating epithelial cells increased significantly over time (P < .05; 0 and 2 hours vs 72, 96, and 120 hours), reaching a maximum of 18.7% + 1.8% (n ¼ 5) at 120 hours ( Figure 2E ). By 16 hours, Ki-67 þ epithelial cells were observed directly adjacent to epithelial LRCs (results not shown) and at 24 hours nascent glands began invaginating into the stroma (results not shown). Ki-67 þ epithelial cells were not detected in vehicle control prepubertal LRC mice 24 hours following injection with oil (n ¼ 3; data not shown). These results confirm that in prepubertal mice, luminal and glandular epithelium proliferate in response to E2. [28] [29] [30] Proliferating epithelial LRCs (BrdU þ Ki-67 þ ) were first Figure 2E ). Nuclear colocalization of BrdU and Ki-67 is indicated by optical sectioning in confocal images and shown as strong yellow signals in the xz and yz planes ( Figure 2D ). BrdU þ Ki-67 þ cells were located in the luminal epithelium rather than the glands ( Figure 2D ) as reported previously. 9 Since all epithelial LRCs (BrdU þ ) at 8 hours were found to colocalize with Ki-67 þ , this indicates that the first cells to proliferate in prepubertal mice after E2 treatment were the epithelial LRCs.
Since Ki-67 is expressed throughout the cell cycle (late G1, S, G2, and M phase), we used the mitosis marker, PH3 to examine a more precise stage of the cell cycle. As expected, fewer PH3 þ compared to Ki-67 þ cells were observed (Figure 2E and F; note scale differences in the y axes). There were no PH3 þ epithelial cells at 0 and 2 hours after E2 ( Figure 2F ), and they first appeared in the luminal epithelium at 8 hours (Supplement Figure 1A ) reaching a peak of 6.73% + 0.40% (n ¼ 4) at 24 hours (Figure 2C and F; P < .05; 0, 2, and 8 vs 24 hours), gradually declining to 1.8% by 120 hours ( Figure 2F ). There was 1 round of mitosis ( Figure 2F ). Mitotic epithelial LRC (PH3 þ BrdU þ ) first appeared at 8 hours ( Figure 2F and Supplement Figure 1A) , reached a maximum at 24 hours (P < .01, 0 and 2 vs 24 hours), and declined thereafter ( Figure 2F ). Thus, in noncycling juvenile endometrium, luminal epithelial LRCs were the first epithelial cells to enter cell cycle and undergo mitosis in response to E2.
Role of LRC in Initiating Epithelial Proliferation in Adult Cycling Endometrium
The role of epithelial LRC in mediating E2-stimulated endometrial epithelial regeneration in adult LRC mice, which had experienced 5 to 6 estrus cycles, was examined in 8-week BrdU pulse-labeled and -chased, OVX mice given a single E2 injection using a similar protocol as for prepubertal mice ( Figure  1A ). As expected, epithelial LRCs (BrdU þ ) were present at a similar frequency (1.81% + 0.28%, n ¼ 9 time points, 4-6 animals/group; P > .05) as in the prepubertal mice ( Figure 2G-L) , despite significant luminal epithelial proliferation that occurs with each estrus cycle. At 0 hour, 5.4% + 1.6% (n ¼ 6) of epithelial cells were Ki-67 þ (Figure 2G, K) , despite 14 days without ovarian E2 and a phytoestrogen-free diet. Ki-67 þ epithelial cells were only found in the luminal epithelium as most glands had regressed following OVX ( Figure 2G ). In adult control mice injected with vehicle, a similar small percentage of KI-67 þ epithelial cells were detected (data not shown). Two hours after E2, 16.3% + 6.6% of epithelial cells were Ki-67 þ and at 8 hours many were found in the lumen ( Figure 2H and Supplement Figure 1B ) and newly forming glands ( Figure 2H ). The majority of epithelial cells were in cell cycle by 48 hours (LI ¼ 88.9% + 4.7%; Figure 2K ). Proliferating epithelial LRCs (BrdU þ Ki-67 þ ) were not detected at 0 time, but by 2 hours most LRCs were Ki-67 þ , and the LI for BrdU þ Ki-67 þ epithelial cells was similar (0.57% + 0.28%) to that for epithelial LRCs (1.75% + 0.57%, n ¼ 5; P ¼ .50; Figure 2K inset), indicating that all epithelial LRCs participated in the proliferative response to E2 .
There was also a basal level of mitotic epithelial cells in 14-day regressed endometrium (0 hour after E2, LI ¼ 1.16% + 0.37% n ¼ 6; Figure 2L increasing to 6.43% + 0.97%, n ¼ 6) at 8 hours ( Figure 2L) , reaching a maximum of 7.65% + 1.81% (n ¼ 6) at 16 hours ( Figure 2I and L) , decreasing to baseline levels at 96 hours ( Figure 2L ) and showing 1 round of mitosis after a single E2 injection. BrdU þ PH3 þ epithelial cells were not observed until 8 hours after E2 ( Figure 2L ), and all LRCs were in mitosis at this time point. This E2-induced increase in mitotic LRC was significant at 8, 16, 24, and 48 hours compared to 0 and 2 hours (P < .05), and all epithelial LRCs underwent mitosis between 16 (0.91% + 0.16%, n ¼ 6; Figure 2I , J, and L) and 96 hours (0.59% + 0.16%, n ¼ 6; Figure 2L ). It appears that in cycling endometrium, luminal and glandular epithelial cells are primed to rapidly respond to E2 by dramatically increasing their numbers.
Role of LRC in Initiating Stromal Proliferation in Adult Cycling Endometrium
The proliferative response of stromal LRC to E2 stimulation in regressed endometrium was examined only in the 8-weekchased BrdU-labeled mice since stromal cell turnover was inadequate in prepubertal mice to sufficiently dilute the BrdU label. This is reflected in the high LI of stromal LRC (23.7% + 5.7%, n ¼ 9) for prepubertal mice after a 4-week chase. In cycling endometrium, stromal LRCs (BrdU þ ) were relatively constant in number over the 0 to 120 hours period after E2 ( Figure 3A , C, D, F, and G) with an average LI of 9.14% + 0.87% (n ¼ 9 time points, 6 animals/group), confirming the previously published data. 9 Proliferating (Ki-67 þ ) stromal cells were first detected 8 hours after E2 treatment with an LI of 2.55% + 0.89%, n ¼ 6 ( Figure 3A , D, and F). Proliferating stromal cells gradually increased reaching significance at 16 hours (16.6% + 3.4%, n ¼ 6; P < .05) and a maximum at 48 hours (23.6% + 7.46%, n ¼ 6; P < .05) after E2 and returned to baseline by 120 hours (Figure 3C and F) . Ki-67 þ stromal cells were not detected in control adult LRC mice 24 hours after injection with oil (data not shown). Proliferating stromal LRCs (BrdU þ /Ki-67 þ ) were first detected 8 hours after E2 treatment ( Figure 3A , D, and F) and were situated near the endometrial-myometrial junction ( Figure 3A and D) or adjacent to the luminal epithelium. In contrast to proliferating epithelial LRCs, only approximately 1 in 8 (12%) of stromal LRCs commenced proliferation at 8 hours (LI ¼ 1.22% + 0.43%, n ¼ 6) after E2 treatment ( Figure 3F ). The BrdU þ /Ki-67 þ LI for stromal cells then gradually increased over time peaking at 24 hours (6.52% + 1.44%, n ¼ 6; P < .001; Figure 3F ) after E2, remaining significantly elevated at 48 and 72 hours compared to 0 and 2 hours (P < .05) and declining to baseline by 120 hours (Figure 3F ). BrdU þ /Ki-67 þ stromal cells were not detected in adult control LRC mice injected with oil (data not shown). These data suggest that a small proportion of stromal LRC are gradually recruited into the cell cycle after E2 treatment of regressed adult mouse endometrium.
Very few stromal cells underwent mitosis and these were first detected 8 hours (LI ¼ 0.57% + 0.07%, n ¼ 6; Figure 3E and G), gradually increasing to 3.46% + 1.29% n ¼ 6; P < .001) at 96 hours after E2 and diminishing to baseline at 120 hours ( Figure 3G ). Mitotic stromal LRCs were not detected until 24 hours after E2 ( Figure 3B , G; 0.32% + 0.04% n ¼ 6) and these gradually increased until 96 hours (1.17% + 0.40%, n ¼ 6, P < .01) and then declined ( Figure 3B , G) in parallel with mitotic stromal cells. BrdU þ PH3 þ cells were not observed in control adult LRC mice injected with vehicle (data not shown). In general, all mitotic stromal cells were LRCs, suggesting that this subpopulation of LRC may be the mesenchymal stem-like cells previously observed in mouse and human endometrium 9, 31 likely responsible for initiating stromal replacement during E2-induced regeneration in mouse endometrium.
Association of ESR1 Expression With Proliferating Endometrial LRC
Our previously published data 9 showed that epithelial LRC did not express ESR1 and that 16% of stromal LRC were ESR1 þ . We therefore examined ESR-1 expression in proliferating epithelial and stromal LRC from juvenile and cycling mouse endometrium in 3-mm serial sections, double IF stained with BrdU/Ki-67 and BrdU/ESR-1, respectively. In prepubertal endometrium, proliferating luminal epithelial LRCs ( Figure 4A ) did not immunostain with ESR-1 despite neighboring nonproliferating, non-LRC epithelial cells showing cytoplasmic immunostaining as previously reported 14 (Figure 4B ). In contrast, some stromal LRCs located near the endometrial-myometrial junction (data not shown) and near the luminal epithelium in cycled adult endometrium colocalized both Ki-67 ( Figure 4C ) and ESR1 ( Figure 4D ), suggesting that E2 can directly induce a subpopulation of ESR1 þ stromal LRC to proliferate. In contrast, it appears that epithelial LRCs respond indirectly to E2 via paracrine signals from surrounding ESR-1 þ stromal niche cells to initiate endometrial regeneration.
Discussion
Epithelial and stromal LRC have recently been identified as candidate stem/progenitor cells in mouse endometrium, the cyclically regenerating mucosal lining of the uterus. [9] [10] [11] In the present study, we have shown that in a prepubertal model of endometrial regeneration ESR1 À epithelial LRCs function as progenitor cells by initiating E2-stimulated growth of glands and luminal epithelium, suggesting an important role for epithelial progenitor cells in regulating endometrial gland development. In contrast, in adult cycling mice, both epithelial LRC and non-LRC rapidly entered the cell cycle and underwent mitosis in response to estrogen to replenish glandular and luminal epithelium in estrogen-depleted mice. These findings suggest that in cycling mice, LRCs play a minor role in the cyclical production of endometrial epithelium and that mature epithelial cells may undergo self-duplication to replenish estrogen-sensitive epithelial cells depleted in the ovariectomy model. Alternatively, there may be many more epithelial progenitors in adult mouse endometrium than are detectable as LRC. While stromal growth during the cyclical turnover of endometrial epithelium is modest in comparison, our data show that a small proportion (12%) of stromal LRC function as stromal stem/progenitor cells (or mesenchymal stem/stromal cells) enabling a modest expansion of the mouse endometrial stromal compartment diminished by estrogen deprivation. Thus, a proportion of the stromal LRCs proliferated in response to E2 to provide adequate stromal support tissue for the rapidly expanding nascent glands and luminal epithelium. These differential responses of endometrial epithelial and stromal LRCs at different physiological developmental stages suggest unique regulation of downstream effectors of estrogen signaling in stimulating and maintaining cellular homeostasis in this dynamically remodeling tissue.
While there is evidence that adult stem cells are relatively quiescent compared to their progeny and can be detected as LRC in situ, it is essential to demonstrate their functionality as stem/progenitor cells. 19 A cell undergoing its final cell division at the time of BrdU labeling will become an LRC but has no capacity for cell division or tissue regeneration, no matter the length of the chase period. A key function of adult stem cells is to maintain tissue homeostasis and regenerate tissue following injury or tissue loss. 3 In this study, we capitalized on the estrogen sensitivity of endometrial cells and used ovariectomy to regress the endometrium and then administered a single 17b-estradiol injection to study the cellular kinetics of estrogen-stimulated endometrial growth. We showed, through colocalization of LRC and the proliferation marker Ki-67 or mitosis marker PH3, that almost all epithelial LRCs proliferated in response to 17b-estradiol in both the prepubertal and the cycling mouse models at the commencement of the epithelial proliferative response (8 and 2 hours, respectively), indicating their capacity to function as adult stem/progenitor cells and restore endometrial epithelial homeostasis. In contrast, only 12% of stromal LRCs initiated stromal cell proliferation upon estrogen replacement. Many of these stromal LRCs were at the endometrial-myometrial junction or directly beneath the luminal epithelium, suggesting that these cells have stromal/ mesenchymal stem cell activity and are responsible for stromal tissue homeostasis. These data also indicate the relative cellular turnover rates in mouse endometrium, with significantly greater rates observed for the epithelium than stroma as previously reported. 29, 30 We predict that these same stromal LRC would also proliferate in response to progesterone to initiate stromal expansion associated with the decidual response, particularly the periluminal stromal LRC. Our recent unpublished observations on stromal LRC distribution using a mouse model of menstrual breakdown and repair (MMBR) 26 suggest that stromal cells proliferate more readily in a protocol where progesterone is administered to induce a decidual response. Therefore, we consider that the 12% of endometrial stromal LRCs that initiated estrogen-induced endometrial stromal regeneration are likely candidate stromal/mesenchymal stem cells because of their ability to proliferate and generate endometrial stroma, an adult stem cell property. In contrast, we consider the 88% of stromal LRCs that failed to proliferate in response to estrogen are likely transit amplifying cells and that an 8-week chase was insufficient to fully dilute the label due to their relatively low cell turnover rate. We also do not consider this population to be candidate endometrial mesenchymal stem/stromal cells. Together, these studies indicate that all epithelial LRCs have proliferative capacity and are likely stem/progenitor cells initiating regenerative responses after estrogen stimulation in both the prepubertal and the adultcycling models, while only a small proportion of stromal LRCs function as stem/progenitor cells.
Many different protocols have been used to assess uterine proliferative responses to sex steroid hormones. Some use multiple priming doses of estrogens, short-or long-acting estrogens in both immature and cycling rodents, and yet others use single-dose estrogen exposures. 32, 33 In order to assess whether the LRCs functioned as stem/progenitor cells, we chose a single dose (5 mg/kg) of 17b-estradiol, sufficient to initiate a robust proliferative response as shown in the present study. In using both immature and adult cycling mice in our models of endometrial regeneration, we demonstrated a striking difference in the magnitude of the proliferative response as measured by Ki-67 IHC, and mitoses by PH3 immunoreactivity. A slower and protracted proliferative response was observed in prepubertal LRC mice with 1 round of mitosis ( Figure 2F ), in which all epithelial LRCs proliferated and drove the response. Nonlabeled epithelial cells also participated in the regenerative response subsequent to LRC proliferation, suggesting that daughter cells generated from LRCs also proliferated. In adult mice that had undergone at least 4 estrus cycles prior to ovariectomy, there was a basal level of Ki-67 þ and mitotic epithelial cells in estrogen-depleted mice, and the proliferative response to 17b-estradiol was extremely rapid with 16% of epithelial cells Ki-67 þ within 2 hours and 60% within 16 hours of treatment, similar to the previously reported values. 34, 35 This rapid proliferation of epithelial cells may result from the shortening of the cell cycle; mainly at the expense of G1, S, and possibly G0 phase. 36 While all epithelial LRCs proliferated, the majority of glandular and luminal epithelial cells had proliferated by 48 hours ( Figure 2L ) and undergone 1 or perhaps 2 rounds of mitosis. This differential response suggests that even in the previously cycled OVX mice, the remaining epithelial cells are very sensitive to rising estrogen levels and are primed for proliferation. Our data also suggest that while all epithelial LRCs proliferate in response to E2 stimulation, they do not appear to initiate epithelial proliferation in regressed adult cycling mouse endometrium. It is possible that BrdU-label retention may not be as sensitive or as specific as a marker of stem/progenitor cells in adult (compared to juvenile) endometrium as is the case for hemopoietic stem cells. 37 Further, it is possible that maintenance of cycling mouse endometrial epithelium does not rely primarily on stem/progenitor cells but rather depends on the expansion of differentiated mature epithelial cells via self-replication as previously shown for the pancreas. 38, 39 These possibilities can only be distinguished using genetic lineage tracking systems such as Cre-lox where the Cre gene is expressed under an endometrial epithelialspecific promoter to excise floxed stop codons flanking an EGFP or LacZ reporter gene. 40 An alternate hypothesis emanating from our data is that there are 2 populations of epithelial stem/progenitor cells with 2 different niches in endometrial epithelium, with different roles in maintaining epithelial cell homeostasis. One population may engage in the long-term growth associated with the development of the glands, while the second population rapidly contributes to the immediate production of epithelial cells as has been demonstrated in other adult stem cell niches, including the bone marrow, intestine, hair follicle, and brain. [40] [41] [42] [43] We suggest that the long-term endometrial epithelial stem/ progenitor cells are detectable as LRC in the luminal epithelium of mouse endometrium labeled with BrdU during postnatal life (this study). 9 The short-term, rapidly responsive endometrial stem/progenitor cell population has not yet been definitively identified to date, although the previous studies using a mouse model of menstrual breakdown and repair suggest this population may be found within a glandular niche. 26 A feature of the rapidly responsive stem/progenitor population is their responsiveness to tissue damage, which is often a key component of the models used to study this population in bone marrow and intestine. The induction of a menstruation-like event through progesterone administration and subsequent withdrawal causing decidual tissue breakdown and shedding in mice that do not normally menstruate is akin to invoking tissue damage. In this model where BrdU labeling is done in adult mice during an artificially induced ''proliferative'' stage, it appears that the cells ultimately responsible for repairing luminal epithelium might come from a second population of slowly cycling cells within the glands in a repair process that does not require estrogen. 44 It would appear that the luminal epithelium contains both a rapidly dividing transit amplifying population that respond rapidly to cell shedding in regions where the lumen is undergoing repair, and a long-term progenitor cell population that selectively responds to estrogen-induced growth signals. In adult mice, this population may be located in segments of the lumen distant to the shedding regions and not undergoing repair. As mentioned above, genetic lineage tracing analysis is required to determine the relative roles of the 2 potential epithelial stem/progenitor cell populations in mouse endometrium and their precise niche locations.
In this study, we have demonstrated that the LRC populations rapidly proliferate in response to E2 in estrogendepleted mice, despite their lack of ESR-1 expression. It would appear that epithelial LRCs do not respond directly to E2 but rather may receive E2 signals indirectly from surrounding ESR-1 þ stromal niche cells via paracrine signals to initiate endometrial regeneration and regulate cell fate decisions. 3 Thus epithelial LRC responsiveness to E2 mirrors earlier studies demonstrating that the mitogenic effect of E2 on endometrial epithelial cells is indirect and mediated via stromal cell ESR-1. 45, 46 Furthermore, ESR-2, present in endometrium at very low levels 47 may modulate estrogen activity by inhibiting ESR-1 to maintain proliferation and differentiation of the endometrium. 14, 48 Further studies are required to conclusively demonstrate a role for ESR þ niche cells in regulating epithelial LRC function in regenerating endometrial epithelium.
Characterization of endometrial stromal LRCs for pluripotency or adult stem cell markers has demonstrated that a small proportion coexpress OCT-4 (6%) and c-KIT (20%). 10 Telomerase which functions to maintain telomeres in proliferating stem cells has been detected in human endometrium, particularly in the basalis layer. 49 Telomerase activity has also been identified in human endometrial side population (SP) cells, a small population considered to be adult stem cells. 50 It would be of interest to determine whether telomerase is expressed in murine endometrial epithelial or stromal LRC. Similarly, Musashi-1, an RNA-binding protein which functions in epithelial stem/progenitor cell self-renewal has been identified in single epithelial cells and small clusters of stromal cells in the basalis of human endometrium, 51 suggesting that Musashi-1 may be a marker of endometrial stem/progenitor cells. Given the known role of Musashi-1 in stem/progenitor cell function, it will be important that future studies examine whether mouse endometrial epithelial and stromal LRC coexpress Musashi-1. Further, markers that have been used to purify human endometrial mesenchymal stem-like cells should also be examined for colocalization with BrdU þ stromal LRC in mouse endometrium. 31 Such studies will determine whether these markers are conserved between human and mouse endometrium.
In conclusion, we have demonstrated distinct proliferative responses of candidate endometrial epithelial stem/progenitor cells (LRCs) to E2 in prepubertal noncycled and adult cycling endometrium. Our data have shown that ESR-1 À epithelial LRC drive E2-induced epithelial growth in the developing endometrium of juvenile mice but play a minor role in regenerating the endometrium in cycling mice. Alternatively, there may be many more epithelial stem/progenitor cells in cycling mouse endometrium than LRC and fewer stromal stem/progenitors than stromal LRC. Our data also demonstrate that epithelial and stromal LRC survive periods of E2 withdrawal as expected of candidate stem/ progenitor cells. Despite the lack of ESR-1 on epithelial LRC, both epithelial and stromal LRC have the capacity to rapidly respond to E2 replacement, proliferate, and participate in endometrial expansion, an important feature if LRC harbor the endometrial stem/progenitor cell population. Furthermore, the lack of ESR-1 suggests an important role of stromal niche cells in mediating epithelial LRC proliferative responses to estrogenic stimuli. Future studies will seek to identify the niche cells of endometrial stem/progenitor cells and to investigate whether mature epithelial cells contribute to endometrial regeneration in the estrus cycles of adult female mice.
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